Profil
Harald Hechenberger worked as a Portfolio Manager at AlpenBank AG from 2001 to 2022.
Anciens postes connus de Harald Hechenberger
| Sociétés | Poste | Fin |
|---|---|---|
AlpenBank AG
 AlpenBank AG Investment ManagersFinance Part of Alpen Privatbank AG, AlpenBank AG is an Austrian company that focuses on chronic heart disease called hypertrophic cardiomyopathy (HCM). Founded in 1983, the company is based in Innsbruck, Austria. HCM is a serious heart condition that affects the heart muscle, causing the walls of the heart to become thicker than they should be. This excessive thickening can cause the heart to become more stiff, leaving less room for blood to fill the heart. As a result, those with HCM may experience fatigue, a fast heartbeat, chest pain, breathing problems, or light-headedness which may interfere with a patient’s ability to participate in activities of daily living. HCM has also been associated with increased risk of atrial fibrillation (irregular heartbeat), stroke, heart failure, and in rare cases, sudden cardiac death. | Membre du Comité d'Investissement | 11/01/2022 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
AlpenBank AG
AlpenBank AG Investment ManagersFinance Part of Alpen Privatbank AG, AlpenBank AG is an Austrian company that focuses on chronic heart disease called hypertrophic cardiomyopathy (HCM). Founded in 1983, the company is based in Innsbruck, Austria. HCM is a serious heart condition that affects the heart muscle, causing the walls of the heart to become thicker than they should be. This excessive thickening can cause the heart to become more stiff, leaving less room for blood to fill the heart. As a result, those with HCM may experience fatigue, a fast heartbeat, chest pain, breathing problems, or light-headedness which may interfere with a patient’s ability to participate in activities of daily living. HCM has also been associated with increased risk of atrial fibrillation (irregular heartbeat), stroke, heart failure, and in rare cases, sudden cardiac death. | Finance |
